ISCHEMIC STROKE Clinical Trial
Official title:
Hair Cortisol and the Risk of Stroke
The purpose of this study is to prospectively examine the relation between ischemic stroke and hair cortisol concentration. The investigators hypothesize that patients with ischemic stroke have higher levels of hair cortisol compared to controls.
Acute physical and emotional stressors are well known triggers of cardiovascular events.
However, it is not clear whether the same association exists with chronic stress. Data on
this issue have been limited by lack of adequate clinical studies and inconclusive results.
One of the possible explanations may be the absence of a reliable mode for quantitative
assessment of chronic stress. To date, studies on the effects of chronic stress on
cardiovascular events have used psychosocial questionnaires. These are subject to recall
bias, as having an event may stimulate the patient to strive harder to identify previous
stressors. Furthermore, most studies on the association of chronic stress and cardiovascular
events have focused on acute coronary events, and only few have examined the association
with stroke.
Both physical and emotional stress activate several neuroendocrine systems, the most
important being the hypothalamic-pituitary-adrenal (HPA) axis that stimulates the production
and secretion of glucocorticoids (especially cortisol) from the adrenal cortex. Therefore,
cortisol is considered to be a "stress hormone" and higher levels of serum cortisol have
been observed in patients with acute stress such as those presenting with acute myocardial
infarction and stroke compared to healthy controls. Moreover, it has been shown that serum
cortisol levels correlates with the severity of the disease and adverse outcome in patients
presenting with stroke.
Cortisol levels are routinely determined from blood, salivary or urinary samples. However,
these methods do not provide information on long term cortisol secretion, accounting for the
variability of HPA axis activity. There is a growing pool of evidence that shows that Hair
Cortisol Concentration (HCC) examination provides a reliable retrospective estimation of
integrated cortisol secretion over a period of several months. Hair grows at a rate of about
1 cm/month, thus 3 cm of hair would give an indication of the cortisol levels over the
previous 3 months. HCC has been evaluated in several clinical settings in which activity of
the HPA axis and cortisol levels over a period of time are of interest. Studies have
demonstrated increased levels of hair cortisol in chronic stress, as well as conditions
associated with stress such as pregnancy , unemployment , PTSD, alcohol withdrawal and
chronic pain and more importantly, in patients admitted to hospital with acute myocardial
infarction. Nevertheless, the association between hair cortisol levels and the risk for
stroke has not yet been studied.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
| Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
| Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
| Recruiting |
NCT05518305 -
Platelet Expression of FcγRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis
|
||
| Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
| Recruiting |
NCT03728738 -
Zero Degree Head Positioning in Hyperacute Large Artery Ischemic Stroke
|
Phase 3 | |
| Terminated |
NCT03396419 -
IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
|
||
| Recruiting |
NCT05065216 -
Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)
|
Phase 2/Phase 3 | |
| Recruiting |
NCT04897334 -
Transcranial Direct Current Stimulation and Rehabilitation to Ameliorate Impairments in Neurocognition After Stroke
|
N/A | |
| Not yet recruiting |
NCT06462599 -
Osteopontin Gene Polymorphism in Stroke Patients in Egypt
|
||
| Not yet recruiting |
NCT06026696 -
Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
|
||
| Not yet recruiting |
NCT06032819 -
Differentiating Between Brain Hemorrhage and Contrast
|
||
| Recruiting |
NCT02910180 -
Genetic, Metabolic, and Growth Factor Repository for Cerebrovascular Disorders
|
||
| Completed |
NCT02922452 -
A Study to Evaluate the Effect of Diltiazem on the Pharmacokinetics (PK) of BMS-986141 in Healthy Subjects
|
Phase 1 | |
| Completed |
NCT03554642 -
Walkbot Robotic Training for Improvement in Gait
|
Phase 3 | |
| Withdrawn |
NCT01866189 -
Identification of Hypoxic Brain Tissues by F-MISO PET in Acute Ischemic Stroke
|
N/A | |
| Recruiting |
NCT03041753 -
Reperfusion Injury After Stroke Study
|
N/A | |
| Completed |
NCT02549846 -
AdminiStration of Statin On Acute Ischemic stRoke patienT Trial
|
Phase 4 | |
| Completed |
NCT01678534 -
Reparative Therapy in Acute Ischemic Stroke With Allogenic Mesenchymal Stem Cells From Adipose Tissue, Safety Assessment, a Randomised, Double Blind Placebo Controlled Single Center Pilot Clinical Trial
|
Phase 2 | |
| Completed |
NCT02610803 -
Paroxysmal Atrial Fibrillation in Patients With Acute Ischemic Stroke
|
N/A |